Cargando…
Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice
Autosomal recessive homozygous or compound heterozygous mutations in FKRP result in forms of muscular dystrophy-dystroglycanopathy varying in age of onset, clinical presentation, and disease progression, ranging from the severe Walker-Warburg, type A,5 (MDDGA5), muscle-eye-brain (MDDGB5) with or wit...
Autores principales: | Tucker, Jason D., Lu, Pei J., Xiao, Xiao, Lu, Qi L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992437/ https://www.ncbi.nlm.nih.gov/pubmed/29858056 http://dx.doi.org/10.1016/j.omtn.2018.02.008 |
Ejemplares similares
-
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
por: Cataldi, Marcela P., et al.
Publicado: (2018) -
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019) -
Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice
por: Blaeser, Anthony, et al.
Publicado: (2016) -
Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice
por: Blaeser, Anthony, et al.
Publicado: (2018) -
Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene
por: Vannoy, Charles Harvey, et al.
Publicado: (2017)